Quinn Opportunity Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-70,900
Closed -$267K 210
2018
Q2
$267K Buy
+70,900
New +$267K 0.04% 156